Sign in
IFRX Stock Price, Chart, Stats & News
InflaRx N.V.
Save
InflaRx N.V. (IFRX) does not currently pay a dividend.
130.74M
Market cap
–
Current P/E
–
Forward P/E
IFRX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -26108.47% |
Operating margin | -173594.03% |
Pretax margin | -155626.07% |
Net margin | -155584.20% |
Effective tax rate | 0.03% |
ROA | -79.42% |
ROE | -81.77% |
D/E | 0.02x |
Interest coverage ratio | -1297.60x |
IFRX valuation
P/E | – |
P/S | 2028.05x |
P/B | 1.28x |
P/CF | -1.57x |
P/FCF | -1.68x |
P/OCF | -1.57x |
PEG | 0.17x |
EV multiple | -1.49x |
About
InflaRx N. V. is a clinical-stage biopharmaceutical firm dedicated to discovering and developing novel inhibitors leveraging C5a technology, primarily operating in Germany and the United States. The company's focus on C5a stems from its critical role as an inflammatory mediator implicated in the progression of various autoimmune and inflammatory diseases.
Similar securities
Based on sector and market capitalization
Report issue